Weston Nichols insider trades
Open-market stock purchases and sales by Weston Nichols, Director at Crinetics Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 21, 2019.
Companies traded
- CRNX Crinetics Pharmaceuticals, Inc: other filings, last Jun 18, 2026